Your treatment matters. Here’s why joining a diabetes clinical trial might be worth considering 2 April 2026 Paid partnership with Canopy Clinical Research Clinical trials are the reason most of today’s treatments exist. Trials help researchers discover better ways to prevent, manage, and treat conditions like diabetes, and they can also offer real benefits to participants. The first insulin trials in the 1920s transformed a once‑fatal diagnosis into a manageable condition. Later studies introduced metformin, and more recent trials paved the way for continuous glucose monitoring and insulin pumps. There are several reasons you might consider participating in a study. Why participate in a clinical trial? Access to enhanced monitoring and health assessments When you join a clinical trial, you are supported by a dedicated medical team who will follow your progress throughout the study. Clinical trials involve regular check-ins, health assessments, and opportunities to speak with the clinical research team about how you are managing your diabetes. New treatment options Clinical trials will often be exploring the effectiveness of new medications or devices that aren’t yet available to the public. For example, Canopy Clinical Research is currently conducting a study investigating a new medication for weight management in type 2 diabetes, as well as a diabetic foot ulcer trial which is investigating a new topical treatment designed to support healing. Your participation can help improve care for the wider diabetes community By taking part in a clinical trial, you can join a community of participants who are shaping history and the next generation of diabetes therapies. How to get involved? If you choose to register your interest in a clinical trial, the process usually begins with a brief pre‑screening call to discuss your health and diabetes history. This is followed by a clinic visit where you can meet the research team and ask any questions you may have. Learn more
Media releases 13 May 2026 Momentum builds following government response to diabetes inquiry The diabetes sector has welcomed the Federal Government’s response to the Parliamentary Inquiry into Diabetes, which provides in-principle support for... Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 3 May 2026 Diabetes and Alzheimer’s: separating fact from fiction While research shows that type 2 diabetes is associated with a higher risk of Alzheimer's, many people with diabetes never develop dementia, and Alzheimer’s disease also affects people without diabetes. Continue Reading